Endpoint definition
↥| Name | CD2_INSITU_BREAST_NOS |
|---|---|
| Long name | Carcinoma in situ of breast, other/unspecified |
| Sex specific endpoint | 2 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
Carcinoma in situ of breast, other/unspecified
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 160 | 160 | - |
| Unadjusted prevalence (%) | 0.07 | 0.13 | - |
| Mean age at first event (years) | 57.92 | 57.92 | - |
| Case fatality at 5-years (%) | 1.25 | 1.25 | - |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | - |
| Recurrence at 6 months (%) | 25.77 | 26.25 | - |
Survival analyses between endpoints
↥Plot
before Carcinoma in situ of breast, other/unspecified
after Carcinoma in situ of breast, other/unspecified
Loading survival analyses plot…
Table
Loading survival analyses table…